|
GB806876A
(en)
|
1956-02-16 |
1959-01-07 |
Wellcome Found |
Improvements in and relating to disposable hypodermic injection devices
|
|
GB873526A
(en)
|
1957-08-14 |
1961-07-26 |
Upjohn Co |
Fluid compositions comprising (acetyl-salicylic acid)-anhydride
|
|
GB887872A
(en)
|
1958-06-25 |
1962-01-24 |
Upjohn Co |
Improvements in or relating to pharmaceutical preparations
|
|
DE1467938C3
(de)
|
1964-05-22 |
1973-12-20 |
F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) |
Wasserdispergierbares Arzneipräparat für Tiere
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
US4906474A
(en)
|
1983-03-22 |
1990-03-06 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
|
US4725442A
(en)
|
1983-06-17 |
1988-02-16 |
Haynes Duncan H |
Microdroplets of water-insoluble drugs and injectable formulations containing same
|
|
US4622219A
(en)
|
1983-06-17 |
1986-11-11 |
Haynes Duncan H |
Method of inducing local anesthesia using microdroplets of a general anesthetic
|
|
US4891225A
(en)
|
1984-05-21 |
1990-01-02 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
|
US4588580B2
(en)
|
1984-07-23 |
1999-02-16 |
Alaz Corp |
Transdermal administration of fentanyl and device therefor
|
|
US4534974A
(en)
|
1984-07-31 |
1985-08-13 |
Carter-Wallace, Inc. |
Pharmaceutical compositions with codeine
|
|
US4626539A
(en)
|
1984-08-10 |
1986-12-02 |
E. I. Dupont De Nemours And Company |
Trandermal delivery of opioids
|
|
US4573995A
(en)
|
1984-10-09 |
1986-03-04 |
Alza Corporation |
Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
|
|
US4804663A
(en)
|
1985-03-27 |
1989-02-14 |
Janssen Pharmaceutica N.V. |
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
|
GB8522453D0
(en)
|
1985-09-11 |
1985-10-16 |
Lilly Industries Ltd |
Chewable capsules
|
|
JPS62298530A
(ja)
|
1986-06-16 |
1987-12-25 |
Otsuka Pharmaceut Co Ltd |
坐薬用医薬組成物
|
|
IT1198449B
(it)
|
1986-10-13 |
1988-12-21 |
F I D I Farmaceutici Italiani |
Esteri di alcoli polivalenti di acido ialuronico
|
|
US4938763B1
(en)
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
|
US5702716A
(en)
|
1988-10-03 |
1997-12-30 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
|
CA2002299A1
(en)
|
1988-11-10 |
1990-05-10 |
Eugene G. Drust |
Compositions for the transdermal delivery of buprenorphine salts
|
|
US5008110A
(en)
|
1988-11-10 |
1991-04-16 |
The Procter & Gamble Company |
Storage-stable transdermal patch
|
|
US5026556A
(en)
|
1988-11-10 |
1991-06-25 |
Norwich Eaton Pharmaceuticals, Inc. |
Compositions for the transdermal delivery of pharmaceutical actives
|
|
US5324519A
(en)
|
1989-07-24 |
1994-06-28 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
US5487897A
(en)
|
1989-07-24 |
1996-01-30 |
Atrix Laboratories, Inc. |
Biodegradable implant precursor
|
|
DE3927113C2
(de)
|
1989-08-17 |
1993-11-25 |
Dolorgiet Gmbh & Co Kg |
Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
|
|
US5096715A
(en)
|
1989-11-20 |
1992-03-17 |
Alko Ltd. |
Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
|
|
US5558880A
(en)
|
1989-12-22 |
1996-09-24 |
Janssen Pharmaceutica Inc. |
Pharmaceutical and other dosage forms
|
|
US5660851A
(en)
|
1989-12-26 |
1997-08-26 |
Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem |
Ocular inserts
|
|
ES2117642T3
(es)
|
1990-05-10 |
1998-08-16 |
Bechgaard Int Res |
Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
|
|
US5069909A
(en)
|
1990-06-20 |
1991-12-03 |
Cygnus Therapeutic Systems |
Transdermal administration of buprenorphine
|
|
JPH0456736A
(ja)
|
1990-06-22 |
1992-02-24 |
Ngk Insulators Ltd |
金属溶湯用フィルターカートリッジ
|
|
JPH0456736U
(https=)
|
1990-09-14 |
1992-05-15 |
|
|
|
US5149543A
(en)
|
1990-10-05 |
1992-09-22 |
Massachusetts Institute Of Technology |
Ionically cross-linked polymeric microcapsules
|
|
WO1992014442A1
(en)
|
1991-02-18 |
1992-09-03 |
Commonwealth Scientific And Industrial Research Organisation |
Composition for use in transdermal administration
|
|
JP2907624B2
(ja)
|
1991-02-28 |
1999-06-21 |
株式会社日本触媒 |
新規含フッ素フタロシアニン化合物、その製造方法、およびそれらを含んでなる近赤外線吸収材料
|
|
JP3145742B2
(ja)
|
1991-09-19 |
2001-03-12 |
日東電工株式会社 |
ゴム系感圧性接着剤とその接着シ―ト
|
|
AU2605592A
(en)
|
1991-10-15 |
1993-04-22 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
|
WO1993023019A1
(en)
|
1992-05-11 |
1993-11-25 |
Sri International |
Transdermal drug delivery systems and related compositions and methods of use
|
|
CA2148823C
(en)
*
|
1992-11-17 |
1999-03-09 |
Welfide Corporation |
Sustained release microsphere preparation containing antipsychotic drug and production process thereof
|
|
TW376319B
(en)
|
1993-04-28 |
1999-12-11 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
|
|
NZ260909A
(en)
|
1993-07-05 |
1995-04-27 |
Takeda Chemical Industries Ltd |
Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
|
|
US5643605A
(en)
|
1993-10-25 |
1997-07-01 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
|
CN1074923C
(zh)
*
|
1993-11-19 |
2001-11-21 |
詹森药业有限公司 |
微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
|
|
CA2474701C
(en)
|
1993-11-19 |
2009-01-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradeable microparticles containing a biologically active agent
|
|
ATE317690T1
(de)
|
1994-04-08 |
2006-03-15 |
Qlt Usa Inc |
Flüssige zusammensetzungen zur arzneistoffabgabe
|
|
US5453425A
(en)
|
1994-07-11 |
1995-09-26 |
Janssen Pharmaceutica N.V. |
Risperidone oral formulation
|
|
WO1996021427A1
(en)
|
1995-01-09 |
1996-07-18 |
Atrix Laboratories, Inc. |
Liquid polymer delivery system
|
|
JP3274579B2
(ja)
|
1995-01-12 |
2002-04-15 |
住友製薬株式会社 |
脳血管障害に伴う精神症候治療剤
|
|
US7833543B2
(en)
*
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US5968542A
(en)
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US6413536B1
(en)
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
PT1006935E
(pt)
|
1995-06-07 |
2005-06-30 |
Durect Corp |
Sistema de entrega controlada liquido de alta viscosidade
|
|
US5736152A
(en)
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
|
US6004969A
(en)
|
1996-04-15 |
1999-12-21 |
National Science Council |
Transdermal delivery of buprenorphine preparations
|
|
ATE223206T1
(de)
|
1996-05-07 |
2002-09-15 |
Alkermes Inc |
Verfahren zur herstellung von mikropartikeln
|
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
|
JP4346696B2
(ja)
|
1996-05-28 |
2009-10-21 |
久光製薬株式会社 |
経皮治療用装置
|
|
CN1191824C
(zh)
|
1996-06-17 |
2005-03-09 |
詹森药业有限公司 |
双面凸的迅速崩解剂型
|
|
ATE203157T1
(de)
|
1996-12-20 |
2001-08-15 |
Alza Corp |
Injizierbare depotgelzubereitung und herstellungsverfahren
|
|
DE19701912C1
(de)
|
1997-01-10 |
1998-05-14 |
Jenapharm Gmbh |
Injizierbares Implantat
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
IT1292396B1
(it)
|
1997-06-23 |
1999-02-08 |
Lisapharma Spa |
Cerotto dermico avente elevata resistenza meccanica,flessibilita' trasparenza e conducibilita' elettrica nel trattamento di affezioni
|
|
AU3273497A
(en)
|
1997-06-23 |
1999-01-04 |
Marco Cecchini |
Inhaling device
|
|
US6622036B1
(en)
|
2000-02-09 |
2003-09-16 |
Cns Response |
Method for classifying and treating physiologic brain imbalances using quantitative EEG
|
|
DE69916911T2
(de)
|
1998-02-10 |
2005-04-21 |
Gen Electric |
Brenner mit gleichmässiger Brennstoff/Luft Vormischung zur emissionsarmen Verbrennung
|
|
ES2359973T3
(es)
|
1998-03-19 |
2011-05-30 |
MERCK SHARP & DOHME CORP. |
Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
|
|
US7208011B2
(en)
|
2001-08-20 |
2007-04-24 |
Conor Medsystems, Inc. |
Implantable medical device with drug filled holes
|
|
US6261583B1
(en)
|
1998-07-28 |
2001-07-17 |
Atrix Laboratories, Inc. |
Moldable solid delivery system
|
|
US6703047B2
(en)
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
|
US6143314A
(en)
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
|
US6565874B1
(en)
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
|
US6194006B1
(en)
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
|
US6355657B1
(en)
|
1998-12-30 |
2002-03-12 |
Atrix Laboratories, Inc. |
System for percutaneous delivery of opioid analgesics
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
US6291013B1
(en)
*
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
|
DE19923551A1
(de)
|
1999-05-21 |
2000-11-30 |
Lohmann Therapie Syst Lts |
Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
|
|
US6461631B1
(en)
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
DE50112157D1
(de)
|
2000-01-11 |
2007-04-19 |
Roland Bodmeier |
Kit zur implantation enthaltend eine trägerphase und ein lösungsmittel
|
|
KR100393478B1
(ko)
|
2000-03-29 |
2003-08-06 |
주식회사종근당 |
자가유화 매트릭스형 경점막·경피흡수제제
|
|
WO2001085731A1
(en)
|
2000-05-05 |
2001-11-15 |
Rpg Life Sciences Limited |
A PROCESS FOR THE PREPARATION OF ANTI-PSCHOTIC 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-one
|
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
WO2002000137A1
(en)
|
2000-06-28 |
2002-01-03 |
Shukla Atul J |
Biodegradable vehicles and delivery systems of biologically active substances
|
|
DE10035889A1
(de)
|
2000-07-24 |
2002-02-14 |
Lohmann Therapie Syst Lts |
Medizinischer Haftkleber mit einem Gehalt an Zucker-Estern
|
|
KR100818875B1
(ko)
|
2000-08-14 |
2008-04-01 |
테바 파마슈티컬 인더스트리즈 리미티드 |
리스페리돈의 제조
|
|
DE10044545A1
(de)
|
2000-09-05 |
2002-04-04 |
Roland Bodmeier |
Retardpartikeldispersion
|
|
IT250575Y1
(it)
|
2000-10-10 |
2003-09-24 |
Gimatic Spa |
Sistema di guida registrabile per griffe di pinze azionate da unfluido
|
|
WO2002038185A2
(en)
|
2000-11-13 |
2002-05-16 |
Atrix Laboratories, Inc. |
Injectable sustained release delivery system with loperamide
|
|
CA2429898C
(en)
|
2000-11-16 |
2011-02-22 |
Durect Corporation |
Devices and methods for cholesterol management
|
|
DK1372729T3
(da)
|
2001-02-23 |
2009-06-22 |
Genentech Inc |
Nedbrydelige polymere til injektion
|
|
US20040018238A1
(en)
*
|
2001-02-26 |
2004-01-29 |
Shukla Atul J |
Biodegradable vehicles and delivery systems of biolgically active substances
|
|
CA2440387A1
(en)
|
2001-03-23 |
2002-10-03 |
Durect Corporation |
Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
|
|
US6558702B2
(en)
|
2001-04-13 |
2003-05-06 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
|
GB0112324D0
(en)
|
2001-05-21 |
2001-07-11 |
Croda Int Plc |
Compounds
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
JP2003063954A
(ja)
|
2001-08-24 |
2003-03-05 |
Saitama Daiichi Seiyaku Kk |
リザーバー型貼付剤
|
|
KR20040058101A
(ko)
|
2001-11-14 |
2004-07-03 |
알자 코포레이션 |
카테터 주입가능한 데포 조성물 및 그의 용도
|
|
NZ533434A
(en)
|
2001-11-14 |
2006-11-30 |
Alza Corp |
Thixotropic gel composition for injectable deposition
|
|
EP1446100B1
(en)
|
2001-11-14 |
2011-05-04 |
Durect Corporation |
Injectable depot compositions and uses thereof
|
|
US20040258731A1
(en)
|
2001-11-21 |
2004-12-23 |
Tsuyoshi Shimoboji |
Preparation approriate for cartilage tissue formation
|
|
BRPI0308360B8
(pt)
|
2002-03-12 |
2021-05-25 |
Ethypharm Sa |
composição termossensível sob forma liquida compreendendo substância organogelificante, utilização de uma composição e processo de preparação de uma composição
|
|
US7041320B1
(en)
|
2002-05-31 |
2006-05-09 |
Biotek, Inc. |
High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
|
|
TWI314464B
(en)
|
2002-06-24 |
2009-09-11 |
Alza Corp |
Reusable, spring driven autoinjector
|
|
TWI353854B
(en)
|
2002-06-25 |
2011-12-11 |
Alza Corp |
Short duration depot formulations
|
|
WO2004011065A1
(en)
|
2002-07-31 |
2004-02-05 |
Alza Corporation |
Injection device providing automatic needle retraction
|
|
DE60325742D1
(de)
|
2002-07-31 |
2009-02-26 |
Alza Corp |
Injizierbare multimodale polymere depotzusammensetzungen und ihre verwendungen
|
|
WO2004020439A2
(en)
|
2002-08-30 |
2004-03-11 |
Sunil Sadanand Nadkarni |
Improved process for preparation of risperidone
|
|
US20040105778A1
(en)
|
2002-10-04 |
2004-06-03 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
|
KR20040034996A
(ko)
|
2002-10-18 |
2004-04-29 |
한미약품 주식회사 |
리스페리돈의 개선된 제조방법
|
|
RU2310450C2
(ru)
|
2002-10-25 |
2007-11-20 |
Пфайзер Продактс Инк. |
Новые депо-препараты для инъекций
|
|
DE10250084A1
(de)
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
ATE418323T1
(de)
|
2002-11-06 |
2009-01-15 |
Alza Corp |
Depot-formulierungen mit verzögerter freisetzung
|
|
ATE482695T1
(de)
|
2002-12-13 |
2010-10-15 |
Durect Corp |
Orale darreichungsform mit flüssigen hochviskosen trägersystemen
|
|
US7501113B2
(en)
|
2003-02-04 |
2009-03-10 |
Philip Morris Usa Inc. |
Aerosol formulations and aerosol delivery of buprenorphine
|
|
WO2004084868A1
(en)
|
2003-03-26 |
2004-10-07 |
Egalet A/S |
Morphine controlled release system
|
|
WO2004094415A1
(en)
|
2003-04-22 |
2004-11-04 |
Synthon B.V. |
Risperidone monohydrochloride
|
|
MXPA05013003A
(es)
|
2003-05-30 |
2006-03-17 |
Alza Corp |
Composiciones de deposito elastomerico implantables, usos de las mismas y metodo para elaboracion.
|
|
JP5229768B2
(ja)
|
2003-06-26 |
2013-07-03 |
シヴィダ・ユーエス・インコーポレイテッド |
Ｉｎ−Ｓｉｔｕゲル化薬物輸送システム
|
|
TWI357815B
(en)
|
2003-06-27 |
2012-02-11 |
Euro Celtique Sa |
Multiparticulates
|
|
FI20045223A7
(fi)
|
2004-06-15 |
2005-12-16 |
Bioretec Oy |
Monitoiminen biohajoava komposiitti ja kirurginen implantti, joka käsittää mainitun komposiitin
|
|
US20050032781A1
(en)
|
2003-08-06 |
2005-02-10 |
Elliot Ehrich |
Methods for administering active agents to CYP 2D6 sensitive patients
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
CA2546482A1
(en)
|
2003-09-01 |
2005-03-10 |
F H Faulding & Co Limited |
Compositions and methods for delivery of biologically active agents
|
|
WO2005037949A2
(en)
|
2003-10-07 |
2005-04-28 |
Chrysalis Technologies Incorporated |
Aerosol formulations of butalbital, lorazepam, ipratropium, baclofen, morphine and scopolamine
|
|
WO2005117830A1
(en)
|
2004-06-04 |
2005-12-15 |
Camurus Ab |
Liquid depot formulations
|
|
US20050106214A1
(en)
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
|
US20050281879A1
(en)
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
JP4610567B2
(ja)
|
2003-12-05 |
2011-01-12 |
ゾゲニクス インコーポレーティッド |
無針注射器の送達準備器具
|
|
JP2007517042A
(ja)
|
2003-12-30 |
2007-06-28 |
デュレクト コーポレーション |
活性物質、好ましくはｇｎｒｈの制御放出のための、好ましくはｐｅｇおよびｐｌｇの混合物を含有するポリマーインプラント
|
|
US8329203B2
(en)
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
CA2553254C
(en)
|
2004-01-12 |
2013-12-17 |
The Trustees Of The University Of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
|
EP1729676A1
(en)
|
2004-03-15 |
2006-12-13 |
Durect Corporation |
Pharmaceutical compositions for administration to a sinus
|
|
IS7290A
(is)
|
2004-05-28 |
2005-11-29 |
Actavis Group |
Lyfjasamsetningar sem innihalda risperidone
|
|
EP1604693A1
(en)
|
2004-06-09 |
2005-12-14 |
Scil Technology GmbH |
In situ forming scaffold, its manufacturing and use
|
|
GB2418854B
(en)
|
2004-08-31 |
2009-12-23 |
Euro Celtique Sa |
Multiparticulates
|
|
JP5254616B2
(ja)
|
2004-09-13 |
2013-08-07 |
クロノ セラピューティクス、インコーポレイテッド |
生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
|
|
US8313763B2
(en)
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
BRPI0516308A2
(pt)
|
2004-10-04 |
2010-06-15 |
Qlt Usa Inc |
composição fluida, métodos de tratamento de uma doença ou disfunção, métodos de liberação local ou sistêmica de um agente biológico, implantes, método de formação de um implante, kit de agente biológico e usos de uma composição fluida
|
|
US8246977B2
(en)
|
2004-10-21 |
2012-08-21 |
Durect Corporation |
Transdermal delivery systems
|
|
CA2586846C
(en)
|
2004-11-10 |
2013-12-31 |
Qlt Usa Inc. |
A stabilized polymeric delivery system
|
|
GB2420976B
(en)
|
2004-11-19 |
2006-12-20 |
Zvi Finkelstein |
Therapeutic implant
|
|
TWI369218B
(en)
|
2004-12-14 |
2012-08-01 |
Novartis Ag |
In situ forming implant for animals
|
|
AU2005316545A1
(en)
|
2004-12-15 |
2006-06-22 |
Qlt Usa, Inc. |
Sustained delivery formulations of octreotide compounds
|
|
WO2006063430A1
(en)
|
2004-12-16 |
2006-06-22 |
Miv Therapeutics Inc. |
Multi-layer drug delivery device and method of manufacturing same
|
|
US9415034B2
(en)
|
2005-01-05 |
2016-08-16 |
National Defense Medical Center |
Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
|
|
NZ565049A
(en)
|
2005-06-17 |
2012-02-24 |
Vital Health Sciences Pty Ltd |
A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
|
|
EP1909689A4
(en)
|
2005-07-18 |
2011-11-16 |
Univ Pennsylvania |
PHARMACEUTICAL IMPLANTS AND METHOD OF USE THEREOF
|
|
US20070020186A1
(en)
|
2005-07-22 |
2007-01-25 |
Alpex Pharma S.A. |
Solid dosage formulations of narcotic drugs having improved buccal adsorption
|
|
EP1912627B1
(en)
|
2005-08-11 |
2016-08-10 |
Promedon S.A. |
Composition comprising polymeric, water-insoluble, anionic particles, processes and uses
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
CA2627292C
(en)
|
2005-10-26 |
2012-04-17 |
Banner Pharmacaps, Inc. |
Hydrophilic vehicle-based dual controlled release matrix system
|
|
MX2008009125A
(es)
|
2006-01-18 |
2008-10-23 |
Qps Llc |
Composiciones farmaceuticas con estabilidad mejorada.
|
|
US20090022798A1
(en)
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US8765178B2
(en)
|
2006-07-19 |
2014-07-01 |
Watson Laboratories, Inc. |
Controlled release formulations and associated methods
|
|
CN105168186A
(zh)
|
2006-10-02 |
2015-12-23 |
Apr应用制药研究股份公司 |
非粘膜粘着性膜剂型
|
|
MX2009003737A
(es)
|
2006-10-05 |
2009-06-16 |
Panacea Biotec Ltd |
Composicion inyectable en deposito y su procedimiento de preparacion.
|
|
SI2079767T1
(sl)
|
2006-10-11 |
2015-01-30 |
Tolmar Therapeutics, Inc. |
Priprava biorazgradljivih poliestrov, ki imajo lastnost majhnega izbruha, s superkritično tekočinsko ekstrakcijo
|
|
US8076448B2
(en)
|
2006-10-11 |
2011-12-13 |
Tolmar Therapeutics, Inc. |
Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
|
|
GB0620661D0
(en)
|
2006-10-18 |
2006-11-29 |
Pharmasol Ltd |
Novel compounds
|
|
HUE025842T2
(en)
|
2007-02-15 |
2016-04-28 |
Tolmar Therapeutics Inc |
Poly (lactide / glycolide) with reduced fracture properties and methods for producing polymers
|
|
CA2679316C
(en)
|
2007-03-02 |
2016-11-29 |
Teika Pharmaceutical Co., Ltd. |
Morphine composition for transdermal absorption, morphine composition storing unit and transdermal absorption preparation using the same
|
|
BRPI0809995A2
(pt)
|
2007-04-03 |
2015-07-21 |
Trimeris Inc |
Composição, e, métodos para a liberação prolongada de um peptídeo em um paciente e para melhorar um sintoma associado com uma infecção por hiv
|
|
DK2167039T3
(en)
|
2007-05-18 |
2017-01-09 |
Durect Corp |
Improved depot formulations
|
|
EP2152315B1
(en)
|
2007-05-25 |
2016-01-06 |
Indivior UK Limited |
Sustained delivery formulations of risperidone compounds
|
|
AU2008296971B2
(en)
|
2007-09-03 |
2014-10-02 |
Nanoshift, Llc |
Particulate compositions for delivery of poorly soluble drugs
|
|
SI2200588T1
(sl)
|
2007-09-25 |
2019-08-30 |
Solubest Ltd. |
Sestavki, ki obsegajo lipofilne aktivne spojine, in postopek za njihovo pripravo
|
|
JP2011506319A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
|
|
FR2926996B1
(fr)
|
2008-01-31 |
2013-06-21 |
Ethypharm Sa |
Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine
|
|
WO2009100222A1
(en)
|
2008-02-08 |
2009-08-13 |
Qps Llc |
Non-polymeric compositions for controlled drug delivery
|
|
CN102231981A
(zh)
|
2008-02-08 |
2011-11-02 |
昌达生物科技公司 |
蛋白质或肽的缓释给药组合物
|
|
JP5286850B2
(ja)
|
2008-03-14 |
2013-09-11 |
大日本印刷株式会社 |
液体用紙容器用包装材料およびその包装材料から製造される液体用紙容器
|
|
EP2254561A2
(en)
|
2008-03-26 |
2010-12-01 |
AllTranz Inc. |
Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
|
|
CN102112107A
(zh)
|
2008-06-03 |
2011-06-29 |
托马医疗科技公司 |
具有改进的释放动力学特征的控制释放共聚物制剂
|
|
EP2291174B1
(en)
|
2008-06-03 |
2015-01-28 |
Tolmar Therapeutics, Inc. |
Flowable composition comprising biocompatible oligomer-polymer compositions
|
|
US8128951B2
(en)
|
2008-09-15 |
2012-03-06 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
|
US8114429B2
(en)
|
2008-09-15 |
2012-02-14 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
|
US8257722B2
(en)
|
2008-09-15 |
2012-09-04 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
|
JP2012524771A
(ja)
|
2009-04-23 |
2012-10-18 |
ロンドンファーマ リミテッド |
中性油を含む舌下用の医薬組成物
|
|
JP5845172B2
(ja)
|
2009-05-01 |
2016-01-20 |
アデア ファーマスーティカルズ，インコーポレイテッド |
高および低用量薬物の組み合わせを含む口腔内崩壊錠組成物
|
|
NZ597283A
(en)
|
2009-06-24 |
2013-07-26 |
Egalet Ltd |
Controlled release formulations
|
|
FR2949061B1
(fr)
|
2009-08-12 |
2013-04-19 |
Debregeas Et Associes Pharma |
Microgranules flottants
|
|
ME03396B
(me)
|
2009-11-18 |
2020-01-20 |
Nektar Therapeutics |
Oblici kisele soli konjugata polimer-lek
|
|
US20130023553A1
(en)
|
2010-01-12 |
2013-01-24 |
Nektar Therapeutics |
Pegylated opioids with low potential for abuse and side effects
|
|
MX343499B
(es)
|
2010-03-15 |
2016-11-08 |
Ipsen Pharma Sas |
Composiciones farmaceuticas de ligandos receptores de secretagoga de la hormona de crecimiento.
|
|
US20110230816A1
(en)
|
2010-03-18 |
2011-09-22 |
Tyco Healthcare Group Lp |
Gels for Transdermal Delivery
|
|
LT2394664T
(lt)
|
2010-05-31 |
2016-09-26 |
Laboratorios Farmaceuticos Rovi, S.A. |
Antipsichozinė injekcinė depozitinė kompozicija
|
|
PT2394663T
(pt)
|
2010-05-31 |
2021-11-26 |
Farm Rovi Lab Sa |
Composições para implantes biodegradáveis injectáveis
|
|
EP2585092A1
(en)
|
2010-06-24 |
2013-05-01 |
Torrent Pharmaceuticals Limited |
Pharmaceutical composition containing goserelin for in-situ implant
|
|
ME02367B
(me)
|
2010-09-21 |
2016-06-20 |
Purdue Pharma Lp |
Analozi buprenorfina kao agonisti i/ili antagonisti opioidnog receptora
|
|
CN103200944B
(zh)
|
2010-11-17 |
2016-05-04 |
赫克萨尔股份公司 |
包含丁丙诺啡的经皮治疗系统
|
|
JP2013543898A
(ja)
|
2010-11-24 |
2013-12-09 |
デュレクト コーポレイション |
生体分解性薬物送達組成物
|
|
WO2012070027A1
(en)
|
2010-11-26 |
2012-05-31 |
University Of The Witwatersrand, Johannesburg |
A drug delivery device
|
|
LT2529756T
(lt)
|
2011-05-31 |
2021-07-26 |
Laboratorios Farmaceuticos Rovi, S.A. |
Risperidono ir (arba) paliperidono implantų kompozicija
|
|
TW201338813A
(zh)
|
2011-12-12 |
2013-10-01 |
洛曼治療系統股份有限公司 |
經皮遞送系統
|
|
US9468599B2
(en)
|
2011-12-27 |
2016-10-18 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US20140134261A1
(en)
|
2012-08-21 |
2014-05-15 |
Trinity Laboratories, Inc. |
Pharmaceutical Compositions Comprising Capsaicin Esters for Treating Pain and Cold Sores
|
|
RU2513514C1
(ru)
|
2012-11-23 |
2014-04-20 |
Общество с ограниченной ответственностью "НПК "Трифарма" |
Фармацевтическая композиция, содержащая налбуфина гидрохлорид, ее применение для лечения болевого синдрома средней и высокой интенсивности и способ получения фармацевтической композиции
|
|
CN103142458B
(zh)
|
2013-01-22 |
2015-09-09 |
莱普德制药有限公司 |
无成瘾性镇痛缓释递药系统的组方与制备方法
|
|
HK1220628A1
(zh)
|
2013-03-11 |
2017-05-12 |
Durect Corporation |
包含高粘度液体载体的可注射控制释放组合物
|
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
|
US9393211B2
(en)
|
2013-03-15 |
2016-07-19 |
Oakwood Laboratories LLC |
High drug load buprenorphine microspheres and method of producing same
|
|
IN2013MU03658A
(https=)
|
2013-11-21 |
2015-09-25 |
Akanksha Bindeshwari Prasad Yadav |
|
|
US10525171B2
(en)
|
2014-01-24 |
2020-01-07 |
The Spectranetics Corporation |
Coatings for medical devices
|